Just this week, two different healthcare companies landed $25 million financings: Massachusetts-based Infraredx and California-based MicuRx Pharmaceuticals. Though it’s not uncommon for companies in the healthcare industry to raise large financings, it’s interesting how many companies raise those large financings in early stage rounds. Since the beginning of 2010, 315 U.S.-headquartered healthcare companies have received at least one VC funding of $25 million or more, according to the PitchBook Platform. About a third of those deals (114) were early stage funding rounds. That figure includes the previously mentioned MicuRx deal, which was a Series B.
Not only did a large portion of the deals fall into the early stage category, but the single largest deal is also an early stage round—Kosmos Biotherapeutics’ $319 million Series A financing in 2010. Most of the next largest deals, however, are late stage rounds, for companies including Intarcia Therapeutics ($210 million raise) and ConforMIS ($168 million).